Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-07-19

Clinical Trial Update: Eval EarlySense Bet Lowenstein Sleeplab

View source ↗

Summary

A clinical trial sponsored by EarlySense Ltd. investigating sleep-related conditions (including obesity and various sleep apnea syndromes) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: EarlySense Ltd. | Conditions: Obese, Sleep Apnea, Obstructive | Status: WITHDRAWN